Mersana Therapeutics, Inc.Mersana Therapeutics, Inc.Mersana Therapeutics, Inc.

Mersana Therapeutics, Inc.

No trades
See on Supercharts

Price target

6.500.00 0.00%
The 8 analysts offering 1 year price forecasts for MRSN have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to MRSN in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

MRSN EPS for the last quarter is −0.16 USD despite the estimation of −0.16 USD. In the next quarter EPS is expected to reach −0.18 USD. Track more of Mersana Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Mersana Therapeutics, Inc. revenue is expected to reach ‪8.50 M‬ USD. Check out Mersana Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, MRSN price target is 6.50 USD with a max estimate of 9.00 USD and a min estimate of 5.00 USD. Check if this forecast comes true in a year, meanwhile watch Mersana Therapeutics, Inc. stock price chart and keep track of the current situation with MRSN news and stock market news.
We've gathered opinions of 9 analysts rating MRSN stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.